Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-derived Products
Clinical/Medical; Investigational New Drug Applications; Pharmacology/Toxicology
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Biotechnology | Drugs & Pharmacology | Investigational New Drugs | New Drug Applications | Study | Toxicology